Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ALAUNOS-THERAPEUTICS-INC-33865/news/ZIOPHARM-Oncology-Announces-Successful-End-of-Phase-2-Meeting-with-FDA-for-Ad-RTS-hIL-12-Gene-Ther-24108477/?utm_source=whatsapp&utm_medium=social&utm_campaign=share